China Health Industries Holdings, Inc. Quarterly Operating Income (Loss) in USD from Q3 2015 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
China Health Industries Holdings, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2015 to Q1 2024.
  • China Health Industries Holdings, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$142K, a 56.8% increase year-over-year.
  • China Health Industries Holdings, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$1.38M, a 25.6% increase year-over-year.
  • China Health Industries Holdings, Inc. annual Operating Income (Loss) for 2023 was -$1.84M, a 11.8% decline from 2022.
  • China Health Industries Holdings, Inc. annual Operating Income (Loss) for 2022 was -$1.65M, a 188% decline from 2021.
  • China Health Industries Holdings, Inc. annual Operating Income (Loss) for 2021 was $1.86M, a 61.9% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$1.38M -$142K +$187K +56.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-06-26
Q4 2023 -$1.57M -$446K -$32.7K -7.93% Oct 1, 2023 Dec 31, 2023 10-Q 2024-04-01
Q3 2023 -$1.54M -$184K +$307K +62.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-21
Q2 2023 -$1.84M -$610K +$13.3K +2.14% Apr 1, 2023 Jun 30, 2023 10-K 2023-11-13
Q1 2023 -$1.86M -$329K -$13.5K -4.29% Jan 1, 2023 Mar 31, 2023 10-Q 2024-06-26
Q4 2022 -$1.84M -$413K -$140K -51.4% Oct 1, 2022 Dec 31, 2022 10-Q 2024-04-01
Q3 2022 -$1.7M -$491K -$54.2K -12.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-21
Q2 2022 -$1.65M -$623K -$314K -102% Apr 1, 2022 Jun 30, 2022 10-K 2023-11-13
Q1 2022 -$1.33M -$316K -$480K -292% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$853K -$273K -$1.4M -124% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-13
Q3 2021 $545K -$437K -$1.32M -149% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $1.86M -$309K -$888K -153% Apr 1, 2021 Jun 30, 2021 10-K/A 2023-04-10
Q1 2021 $2.75M $164K -$1.16M -87.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $3.91M $1.13M -$825K -42.3% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-14
Q3 2020 $4.74M $882K -$157K -15.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $4.89M $580K -$526K -47.6% Apr 1, 2020 Jun 30, 2020 10-K 2021-09-20
Q1 2020 $5.42M $1.32M +$255K +23.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $5.16M $1.95M +$474K +32.1% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-10
Q3 2019 $4.69M $1.04M +$126K +13.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 $4.56M $1.11M +$1.09M +5640% Apr 1, 2019 Jun 30, 2019 10-K 2020-10-13
Q1 2019 $3.48M $1.07M +$1.35M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 $2.12M $1.48M +$1.51M Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-14
Q3 2018 $609K $913K +$1.08M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$467K $19.3K +$95.8K Apr 1, 2018 Jun 30, 2018 10-K 2019-09-11
Q1 2018 -$563K -$286K -$208K -264% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$355K -$36.4K -$178K -126% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-14
Q3 2017 -$177K -$163K -$9.12K -5.91% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$168K -$76.5K +$50.2K +39.6% Apr 1, 2017 Jun 30, 2017 10-K 2018-09-28
Q1 2017 -$218K -$78.7K +$6.18K +7.28% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$224K $142K +$218K Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-09
Q3 2016 -$442K -$154K -$161K -2563% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$281K -$127K Apr 1, 2016 Jun 30, 2016 10-K 2017-09-27
Q1 2016 -$84.8K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$75.8K Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-14
Q3 2015 $6.26K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.